ScholarLens Back to search
2013•China Medicine and PharmacyRequires access

Diagnostic value of serum CEA,CA50,CA19-9 in gastric cancer

Xiong Hongdian

Open publisher page 0 citations

Abstract

Objective To investigate the clinical significance of serum tumor markers CEA,CA50,CA19-9 in gastric cancer. Methods The serum levels of CEA,CA50,CA19-9 were detected by radioimmunoassay determination in 60 patients with gastric cancer,60 cases with benign gastric diseases and 60 normal healthy subjects. The differences among the three groups were compared. Results The serum levels of CEA、CA50、CA19-9 in gastric cancer patients were obviously higher than those in the group with benign gastric diseases and in the normal healthy subjects (P 0.05). While the health difference between control and gastric group had no statistical significance (P 0.05). Conclusion The serum levels of CEA,CA50,CA19-9 are higher in patients with gastric cancer. The serum levels of CEA,CA50,CA19-9 are valuable in auxiliary diagnosis of gastric cancer.

About this research paper

What this paper is about

Objective To investigate the clinical significance of serum tumor markers CEA,CA50,CA19-9 in gastric cancer. Methods The serum levels of CEA,CA50,CA19-9 were detected by radioimmunoassay determination in 60 patients with gastric cancer,60 cases with benign gastric diseases and 60 normal healthy subjects. The differences among the three groups were compared. Results The serum levels of CEA、CA50、CA19-9 in gastric cancer patients were obviously higher than those in the group with benign gastric diseases and in the normal healthy subjects (P 0.05). While the health difference between control and gastric group had no statistical significance (P 0.05). Conclusion The serum levels of CEA,CA50,CA19-9 are higher in patients with gastric cancer. The serum levels of CEA,CA50,CA19-9 are valuable in auxiliary diagnosis of gastric cancer.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the clinical significance of serum tumor markers CEA,CA50,CA19-9 in gastric cancer. Methods The serum levels of CEA,CA50,CA19-9 were detected by radioimmunoassay determination in 60 patients with gastric cancer,60 cases with benign gastric diseases and 60 normal healthy subjects. The differences among the three groups were compared. Results The serum levels of CEA、CA50、CA19-9 in gastric cancer patients were obviously higher than those in the group with benign gastric diseases and in the normal healthy subjects (P 0.05). While the health difference between control and gastric group had no statistical significance (P 0.05). Conclusion The serum levels of CEA,CA50,CA19-9 are higher in patients with gastric cancer. The serum levels of CEA,CA50,CA19-9 are valuable in auxiliary diagnosis of gastric cancer.

Key concepts: Medicine, CA19-9, Internal medicine, Cancer, Gastroenterology, Clinical significance, Radioimmunoassay, Tumor marker

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Diagnostic value of serum CEA,CA50,CA19-9 in gastric cancer — Research Paper | ScholarLens